Alaunos Therapeutics Inc.

NASDAQ: TCRT · Real-Time Price · USD
2.27
-0.13 (-5.42%)
At close: Aug 15, 2025, 3:59 PM
2.20
-2.87%
After-hours: Aug 15, 2025, 07:31 PM EDT

Alaunos Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10K 5K 2.92M 398K
Cost of Revenue
n/a 4.8M 2.76M 740K
Gross Profit
10K -4.8M 163K -342K
Operating Income
-4.81M -34.27M -35.1M -77.55M
Interest Income
n/a n/a n/a n/a
Pretax Income
-4.68M -35.14M -37.73M -78.75M
Net Income
-4.68M -35.14M -37.6M -76.89M
Selling & General & Admin
4.46M 12.22M 13.14M 27.56M
Research & Development
362K 16.28M 25.02M 49.64M
Other Expenses
n/a 971K 529K n/a
Operating Expenses
4.82M 29.47M 38.16M 77.21M
Interest Expense
n/a 1.92M 3.15M 1.18M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
4.82M 34.27M 38.16M 77.21M
Income Tax Expense
n/a n/a -133K -1.86M
Shares Outstanding (Basic)
1.6M 1.6M 1.45M 1.43M
Shares Outstanding (Diluted)
1.6M 1.6M 1.45M 1.43M
EPS (Basic)
-2.92 -21.97 -25.97 -53.8
EPS (Diluted)
-2.92 -21.97 -25.97 -53.8
EBITDA
-4.68M -30.9M -31.82M -74.97M
EBIT
-4.68M -33.22M -34.58M -77.56M
Depreciation & Amortization
2K 2.31M 2.76M 2.6M